INS and diabetes mellitus: The basic principle of the stem cell-based approach in diabetes therapy following cadaveric islet transplantation using Edmonton protocol (Shapiro et al. 2000) is to differentiate hPSCs into insulin-expressing β-cells and transplant them to diabetic patients which helps to circumvent healthy islet donor shortage.